Top 17 investors in Western Europe that took part in the most Private Equity funding rounds in Biotechnology industry over the recent years

Intro

The top 17 investors according to the total amount of funding rounds. These are VC funds and corporate investors in Western Europe that have invested in Private Equity stage over the last 3 years. They are actively investing in Biotechnology industry.
Biotechnology is the use of biology to make or develop products. It includes biopharmaceutical, genetics, and neuroscience.

Amount of Private Equity funding rounds is 20, which is 1.5% of the total amount of rounds in the Biotechnology industry in Western Europe over the last 3 years.

Top 17 investors in Western Europe that took part in the most Private Equity funding rounds in Biotechnology industry over the recent years
data provided by Unicorn Nest

Key takeaways

• Funds Geography – The most common country among top VCs is The United Kingdom which hosts 6 funds. There are also funds from France, Switzerland and Sweden. The most common city is London which is home to 5 funds. There are also funds from Paris, Zürich and Zug. VCs tend to invest in startups from The United States, but also invest in startups from France, The United Kingdom, and Switzerland. For 7 funds in the sample, the country of the funds’ establishment and the country of their most frequent investments coincide.
• Industry Focus – The funds’ most common field for investments is Finance. They also invest in Medical Service, Business Development and Bio & Nano Technology.
• Important Years – The oldest fund in the sample was founded in 1953 and the newest one in 2017. In 1995 the most amount of funds were founded. VCs in the sample made the most deals in the period from 2009 to 2021. For some funds, 2016 was the year with the most amount of deals. The biggest amount of successful exits happened between 2006 and 2021 years. For some funds, 2020 became the year with the most successful exits.
• Investments – Usually VCs take part in 2 funding rounds per year, sometimes in 2 – 6. The minimum number of funding rounds for VCs in the sample is 8, the maximum is 232. Average number of funding rounds is 85.4 while median is 52.0. The most common amount of funding rounds for VCs in the sample is 49. Minimum amount of lead investments for funds is 0 and maximum is 83. Average amount of lead investments is 23.1 while median is 11.0. The most common amount of lead investments is 6. Index of difference in percentage points of lead investments from the average is between -45.19 and 29.0 for funds in the sample. The average value for this difference is 0.01 and the median is 4.0. It means that these funds act as lead investors more often than other funds. The most common value is 29.0.
• Typical Rounds – VCs usually participate in rounds with 3 – 4 investors. Less often in rounds with 5 – 6 investors. VCs in the sample have an average round size of 10 – 50 million or 50 – 100 million. A Funds’ average multiplicator for portfolio companies at the last known valuation is close to zero at minimum and 19.2 at maximum. Average value for this multiplicator is 4.25 and median is 2.81.